Probiotics in pregnancy for infant atopic eczema

Higher risk is determined by a family history of allergic disease. There is a strong hereditary component to infant atopic eczema: if both parents have a history of eczema, the offspring risk is 60–80%.

The gut of a healthy fetus is sterile. After delivery, the mother’s gut flora colonises the infant’s gut.
Probiotics may reduce the relative incidence of atopic eczema by almost 80%. In trials, the favourable effect was similar across different periods of probiotic use (ie after delivery only or also during pregnancy), the receiver(s) of the probiotics (ie mother, child or both) and the duration of probiotic use.

Probiotics have several actions in the gut, including actively competing with pathogens for nutrition, making gut contents acidic, secreting local antimicrobial agents and enhancing specific and non-specific immune responses. The composition of gut flora may reduce allergies by driving maturation of the immune system.

Evidence suggests that probiotics are safe for the vast majority of people. Although there is little risk of sepsis, these agents should potentially be avoided in patients who are immunocompromised, severely debilitated, critically ill or postoperative.

Probiotics are safe in both pregnant women and infants, and are not associated with serious adverse effects.

Some people experience bloating and diarrhoea.

Many different formulations of probiotics (capsules, powders, sachets) are available from supermarkets, pharmacies and health food stores. Products containing probiotics that are classed as foodstuffs (eg yoghurt) are not subjected to the same rigorous processes for labelling and listing as are applied to medicines.

Probiotics containing Lactobacillus species are widely available.

In medical trials, probiotic supplementation was generally started in the mother at 34­–36 weeks of gestation and continued in the postpartum period until the baby was 3–6 months of age (or until weaned). Some of the infants in the trials were given probiotics mixed in breast milk or formula, either concurrently or independently of the mother taking probiotics.

Lactobacillus species (particularly Lactobacillus rhamnosus GG) are typically used, most commonly at a strength of 2 x 10¹⁰ CFUs (colony-forming units) daily. However, there does seem to be a moderate effect seen across all probiotics tested.

Probiotics may be taken alone or with food/fluid to manufacturer’s directions.

NHMRC Level I evidence.